Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Ljubljana Stock Exchange  >  Krka, d. d.    KRKG   SI0031102120

KRKA, D. D.

(KRKG)
  Report
End-of-day quote. End-of-day quote Ljubljana Stock Exchange - 11/24
87.6 EUR   -0.90%
11/19KRKA D D : Reports Business Results for the First Nine Months Ended 30 September 2020
PU
11/16KRKA, D. D. : quaterly earnings release
07/21KRKA, D. D. : Ex-dividend day for final dividend
FA
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Ljubljana Stock Exchange
11/18/2020 11/19/2020 11/20/2020 11/23/2020 11/24/2020 Date
82.4 84.6 86.2 88.4 87.6 Last
3452 11392 9365 16366 5894 Volume
-0.24% +2.67% +1.89% +2.55% -0.90% Change
Financials
Sales 2020 1 563 M 1 859 M 1 859 M
Net income 2020 229 M 273 M 273 M
Net cash position 2020 288 M 343 M 343 M
P/E ratio 2020 11,6x
Yield 2020 4,95%
Sales 2021 1 599 M 1 902 M 1 902 M
Net income 2021 252 M 299 M 299 M
Net cash position 2021 339 M 403 M 403 M
P/E ratio 2021 10,9x
Yield 2021 5,54%
Capitalization 2 743 M 3 259 M 3 263 M
EV / Sales 2020 1,57x
EV / Sales 2021 1,50x
Nbr of Employees 11 503
Free-Float 79,4%
More Financials
Company
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and... 
Sector
Pharmaceuticals
Calendar
03/04Earnings Release
More about the company
Notations Surperformance© of Krka, d. d.
Trading Rating : Investor Rating :
More Ratings
All news about KRKA, D. D.
11/19KRKA D D : Reports Business Results for the First Nine Months Ended 30 September..
PU
11/16KRKA, D. D. : quaterly earnings release
07/21KRKA, D. D. : Ex-dividend day for final dividend
FA
05/21KRKA D D : Reports First Quarter 2020 Business Results
PU
05/18KRKA, D. D. : quaterly earnings release
04/09KRKA D D : Proposed dividend for Krka shareholders 32.8% higher than last year
PU
03/19KRKA D D : Presents the 2019 Unaudited Performance Results
PU
01/30KRKA D D NOVO MESTO : Estimation of Krka Business Performance in 2019
PU
2019KRKA D D NOVO MESTO : receives two prestigious awards by the Ljubljana Stock Exc..
PU
2019KRKA D D NOVO MESTO : Presents January–September 2019 Operating Results
PU
2019KRKA D D NOVO MESTO : World Mental Health Day
PU
2019KRKA D D NOVO MESTO : new Development-Control Centre 4 expands the company's cap..
PU
2019KRKA D D NOVO MESTO : Striving for greater mobility worldwide
PU
2019KRKA D D NOVO MESTO : Life is a collage of precious memories, but is that true f..
PU
2019KRKA D D NOVO MESTO : Live longer. Live better. Can we?
PU
More news
News in other languages on KRKA, D. D.
11/16KRKA, D. D. : Veröffentlichung des Quartalsergebnisses
11/16KRKA, D. D. : publication des résultats trimestriels
05/18KRKA, D. D. : publication des résultats trimestriels
05/18KRKA, D. D. : Veröffentlichung des Quartalsergebnisses
2014Bruxelles inflige une amende à six laboratoires pharmaceutiques
More news
Chart KRKA, D. D.
Duration : Period :
Krka, d. d. Technical Analysis Chart | KRKG | SI0031102120 | MarketScreener
Technical analysis trends KRKA, D. D.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 92,50 €
Last Close Price 87,60 €
Spread / Highest target 20,4%
Spread / Average Target 5,59%
Spread / Lowest Target -22,4%
EPS Revisions
Managers
NameTitle
Jože Colaric President-Management Board & CEO
Jože Mermal Chairman-Supervisory Board
Brane Kastelec Finance Director
Aleš Rotar Director-Pharmaceutical Research & Development
Miran Kapš Director-Information Technology
Sector and Competitors